Secular Trend of Hospital‐Acquired Candidemia among Intensive Care Unit Patients in the United States during 1989–1999
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
We describe the annual incidence of primary bloodstream infection (BSI) associated with Candida albicans and common non-albicans species of Candida among patients in intensive care units that participated in the National Nosocomial Infections Surveillance system from 1 January 1989 through 31 December 1999. During the study period, there was a significant decrease in the incidence of C. albicans BSI (P<.001) and a significant increase in the incidence of Candida glabrata BSI (P=.05).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there was a statistically significant increase in the rate of infections due to Candida glabrata, which is now the second most common cause of bloodstream and mucosal infections in the United States (6, 48, 65, 69).”
From Functional Genomic Analysis of Fluconazole Susceptibility in the Pathogenic Yeast Candida glabrata : Roles of Calcium Signaling and Mitochondria (2004) · cites this paper as [65]
In the citing paper
“there was a significant decrease in the annual incidence of infections with Candida albicans, the most common cause of Candida BSI, in this group of patients in the 1990s (40).”
In the citing paper
“During the same time period, there was a significant increase in the incidence of C. glabrata BSI (40).”
In the citing paper
“Although C. albicans continues to be the single most common species causing candidemia, results from this study confirm prior reports that, compared to the situation in the 1980s, a larger proportion of Candida BSI in the United States is now caused by Candida species other than C. albicans (20, 40).”
In the citing paper
“A significant increase in C. glabrata BSI was also noted (from 0.2 per 10,000 CVC days in 1989 to 0.5 per 10,000 CVC days in 1999; P = 0.05)”
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989.
Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T., Edwards, J. R., Tolson, J., Henderson, T., Martone, W. J., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90349-3 · Cited by 880
Self-citationEpidemiology of nosocomial fungal infections
Fridkin, S. K., & Jarvis, W. R. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.499 · Cited by 782
Self-citation1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
Hughes, W. T., Armstrong, D., Bodey, G. P., Brown, A. E., Edwards, J. E., Feld, R., Pizzo, P., Rolston, K. V. I., Shenep, J. L., & Young, L. S. (1997) · Clinical Infectious Diseases · doi:10.1086/513764 · Cited by 672
Self-citationNosocomial infection rates in adult and pediatric intensive care units in the United States
Jarvis, W. R., Edwards, J. R., Culver, D. H., Hughes, J. M., Horan, T., Emori, T. G., Banerjee, S., Tolson, J., Henderson, T., Gaynes, R. P., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90367-7 · Cited by 497
Self-citationKao, A. S., Brandt, M. E., Pruitt, W. R., Conn, L. A., Perkins, B. A., Stephens, D. S., Baughman, W. S., Reingold, A. L., Rothrock, G. A., Pfaller, M. A., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/313450 · Cited by 457
Self-citationKomshian, S. V., Uwaydah, A. K., Sobel, J. D., & Crane, L. R. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.379 · Cited by 457
Risk Factors for Hospital-Acquired Candidemia: A Matched Case-Control Study
Wey, S. B. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390100145030 · Cited by 369
Research works printed but not linked: 3
- Jarvis WR, 1991, National Nosocomial Infections Surveillance System. Am J Med, 91, 185S
- 10.1001/archinte.149.10.2349 · DOI · Paper page
- National Nosocomial Infections Surveillance, 2000, MMWR Morb Mortal Wkly Rep, 49, 149
Cited by
Items 301–400 of 664
Kamikawa, Y., Mori, Y., Nagayama, T., Fujisaki, J., Hirabayashi, D., Sakamoto, R., Hamada, T., & SUGIHARA, K. (2014) · BMC Oral Health · doi:10.1186/1472-6831-14-14 · Cited by 41
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
Mikulska, M., Bassetti, M., Ratto, S., & Viscoli, C. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.007 · Cited by 37
Chen, L.-Y., Liao, S.-Y., Kuo, S., Chen, S.-J., Chen, Y., Wang, F.-D., Yang, S.-P., & Fung, C. (2011) · Journal of Hospital Infection · doi:10.1016/j.jhin.2010.12.007 · Cited by 33
Navarathna, D. H. M. L. P., Pathirana, R. U., Lionakis, M. S., Nickerson, K. W., & Roberts, D. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164449 · Cited by 34
Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases
Cornely, O. A., Pappas, P. G., Young, J. H., Maddison, P., & Ullmann, A. J. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.557062 · Cited by 34
Anidulafungin: a new echinocandin for candidal infections
de la Torre, P., & Reboli, A. C. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.1.45 · Cited by 33
Chen, T., Chen, Y., Chen, Y., & Lu, P. (2012) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2011.11.011 · Cited by 35
Taverna, C. G., Bosco‐Borgeat, M. E., Murisengo, O. A., Davel, G., Boité, M. C., Cupolillo, E., & Canteros, C. E. (2013) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-0276108022013009 · Cited by 33
Enache-Angoulvant, A., Guitard, J., Grenouillet, F., Martin, T., Durrens, P., Fairhead, C., & Hennequin, C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00688-11 · Cited by 31
Oral epithelium–Candida glabrata interactions in vitro
Li, L., & Dongari‐Bagtzoglou, A. (2007) · Oral Microbiology and Immunology · doi:10.1111/j.1399-302x.2007.00342.x · Cited by 29
Guitard, J., Atanasova, R., Brossas, J., Meyer, I., Gits‐Muselli, M., Marinach, C., Vellaissamy, S., Angoulvant, A., Mazier, D., & Hennequin, C. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02913-14 · Cited by 48
Triazole Use in the Nursery: Fluconazole, Voriconazole, Posaconazole, and Ravuconazole
Watt, K., Manzoni, P., Cohen‐Wolkowiez, M., Rizzollo, S., Boano, E., Jacqz-Aigrain, É., & Benjamin, D. K. (2013) · Current Drug Metabolism · doi:10.2174/138920013804870583 · Cited by 34
Epidemiología de la candidemia en UCI
Galván, B., & Mariscal, F. (2006) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(06)70005-5 · Cited by 38
Metwally, L. A., Walker, M. J., Coyle, P. V., Hay, R. J., Hedderwick, S. A., McCloskey, B. V., O’Neill, H. J., Webb, C. H., & McMullan, R. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.04.003 · Cited by 31
Virulence Markers and Antifungal Susceptibility Profile of Candida glabrata: An Emerging Pathogen
Deorukhkar, S. C. (2014) · British Microbiology Research Journal · doi:10.9734/bmrj/2014/5806 · Cited by 34
Ruan, S., Chu, C., & Hsueh, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00323-08 · Cited by 29
Management of Invasive Candidiasis in the Intensive Care Unit
Playford, E. G., Lipman, J., & Sorrell, T. C. (2010) · Drugs · doi:10.2165/10898550-000000000-00000 · Cited by 30
Neoh, C. F., Slavin, M. A., Chen, S. C. ‐., Stewart, K., & Kong, D. C. M. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.08.010 · Cited by 33
Abbes, S., Sellami, H., Sellami, A., Makni, F., Mahfoudh, N., Makni, H., Khaled, S., & Ayadi, M. A. (2010) · Medical Mycology · doi:10.3109/13693786.2010.493561 · Cited by 32
Lott, T. J., Frade, J. P., Lyon, G. M., Iqbal, N. J., & Lockhart, S. R. (2012) · Medical Mycology · doi:10.3109/13693786.2011.592153 · Cited by 35
Baddley, J. W., Patel, M., Jones, M., Cloud, G. A., Smith, A. C., & Moser, S. A. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.06.004 · Cited by 31
Towards New Antifolates Targeting Eukaryotic Opportunistic Infections
Liu, J., Bolstad, D. B., Bolstad, E. S. D., Wright, D. L., & Anderson, A. C. (2009) · Eukaryotic Cell · doi:10.1128/ec.00298-08 · Cited by 29
Antifungal Susceptibility Analysis of Clinical Isolates of Candida parapsilosis in Iran.
Lotfali, E., Kordbacheh, P., Mirhendi, H., Zaini, F., Ghajari, A., Mohammadi, R., Noorbakhsh, F., Moazeni, M., Fallahi, A. A., & Rezaie, S. (2016) · PubMed Central · Cited by 31
Candidemia in Children: A 16-year Longitudinal Epidemiologic Study
Silvester, E. J., Watanabe, M., Pittet, L. F., Boast, A., Bryant, P. A., Haeusler, G. M., Daley, A. J., Curtis, N. C., & Gwee, A. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003082 · Cited by 29
Al‐Tawfiq, J. A., & Abed, M. S. (2009) · Saudi Medical Journal · doi:10.15537/1658-3175.4832 · Cited by 27
Tay, S. T., Abidin, I. A. Z., Hassan, H. H., & Ng, K. P. (2011) · Medical Mycology · doi:10.3109/13693786.2010.551424 · Cited by 32
Pharmacotherapy of yeast infections
Gómez‐López, A., Zaragoza, Ó., Rodríguez-Tudela, J. L., & Cuenca‐Estrella, M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.16.2801 · Cited by 38
Arora, P., Dilbaghi, N., & Chaudhury, A. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1275-1 · Cited by 29
Morrison, C. J., Hurst, S. F., & Reiss, E. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.5.835-848.2003 · Cited by 29
Shigemura, K., Osawa, K., Jikimoto, T., Yoshida, H., Hayama, B., Ohji, G., Iwata, K., Fujisawa, M., & Arakawa, S. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2013.141 · Cited by 30
Candida albicans identification: comparison among nine phenotypic systems and a multiplex PCR
Liguori, G., Onofrio, V. D., Gallé, F., Lucariello, A., Albano, L., Catania, M. R., & Guida, M. (2010) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2010.51.3.225 · Cited by 36
Milazzo, L., Peri, A. M., Mazzali, C., Grande, R., Cazzani, C., Ricaboni, D., Castelli, A., Raimondi, F., Magni, C. F., Galli, M., et al. (2014) · Mycopathologia · doi:10.1007/s11046-014-9786-9 · Cited by 29
Pitangui, N. D. S. (2013) · Tropical Medicine & Surgery · doi:10.4172/2329-9088.1000141 · Cited by 34
Seddiki, S. M. L., Boucherit-otmani, Boucherit, Badsi-amir, Taleb, & Kunkel (2013) · International Journal of General Medicine · doi:10.2147/ijgm.s38065 · Cited by 38
Abastabar, M., Hosseinpoor, S., Hedayati, M. T., Shokohi, T., Valadan, R., Mirhendi, H., Mohammadi, R., Âghili, S. R., Rahimi, N., Aslani, N., et al. (2016) · Current Medical Mycology · doi:10.18869/acadpub.cmm.2.4.1 · Cited by 29
Shi, Y., Jiang, K., Zheng, R., Fu, J., Yan, L., Gu, Q., Zhang, Y., & Lin, F. (2019) · Chemistry & Biodiversity · doi:10.1002/cbdv.201800510 · Cited by 28
Observational study on candidaemia at a university hospital in southern Italy from 1998 to 2004
Caggiano, G., Iatta, R., Laneve, A., Manca, F., & Montagna, M. T. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01452.x · Cited by 34
A Single‐Centre 10‐Year Experience with Candida Bloodstream Infections
Labbé, A., Pépin, J., Patiño, C., Castonguay, S., Restieri, C., & Laverdière, M. (2008) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2009/731070 · Cited by 31
Management ofCandidainfections in the adult intensive care unit
Cruciani, M., & Serpelloni, G. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.2.175 · Cited by 34
A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.
Diekema, D. J., Messer, S. A., Hollis, R. J., Boyken, L. B., Tendolkar, S., Kroeger, J. S., Jones, R. N., & Pfaller, M. A. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.11.001 · Cited by 26
Epidemiología de las candidiasis invasoras en población pediátrica y adulta
del Palacio, A., Villar, J., & Alhambra, A. (2009) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(09)70002-6 · Cited by 35
Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri
Zameitat, E., Knecht, W., Piškur, J., & Löffler, M. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.05.017 · Cited by 28
The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia
Sobel, J. D. (2007) · Current Fungal Infection Reports · doi:10.1007/s12281-007-0007-6 · Cited by 26
Complicated Intra-abdominal Infections: A Focus on Appendicitis and Diverticulitis
Spirt, M. J. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.01.2098 · Cited by 25
The epidemiology of fungal infections
Lockhart, S. R., Diekema, D. J., & Pfaller, M. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00001-3 · Cited by 25
Vázquez, J. A., & Sobel, J. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_11 · Cited by 58
Therapeutic Guidelines in Systemic Fungal Infections
Richardson, & Bl, J. (2003) · Cited by 25
Catheter-related fungemia caused by Candida intermedia
Ruan, S., Chien, J., Hou, Y.-C., & Hsueh, P. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.03.015 · Cited by 27
Candidainfections in the intensive care unit: epidemiology, risk factors and therapeutic strategies
Bassetti, M., Righi, E., Tumbarello, M., Biagio, A. D., Rosso, R., & Viscoli, C. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.5.875 · Cited by 26
Impact of Fluconazole Prophylaxis on Cortisol Levels in Critically Ill Surgical Patients
Magill, S. S., Puthanakit, T., Swoboda, S. M., Carson, K. A., Salvatori, R., Lipsett, P. A., & Hendrix, C. W. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2471-2476.2004 · Cited by 27
Li, R., LU, Y.-L., LU, Y.-B., Zhang, H., Huang, L., Yin, Y., Zhang, L., Liu, S., Lu, Z., & Sun, Y. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2838 · Cited by 24
Ibuprofen-Mediated Reversal of Fluconazole Resistance in Clinical Isolates of Candida
Sharma, M., Biswas, D., Kotwal, A., Thakuria, B., Kakati, B., Chauhan, B. S., & Patras, A. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/10094.5494 · Cited by 28
Surveillance study of candidemia in cancer patients in North China
Li, D., Zhang, W., Zheng, S., Ma, Z., Zhang, P., & Liu, Z. (2012) · Medical Mycology · doi:10.3109/13693786.2012.727481 · Cited by 23
Kumar, D., Bhattacharyya, S., Gupta, P. K., Banerjee, G., & Singh, M. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/14119.6735 · Cited by 27
Fadda, M. E., Podda, G., Pisano, M. B., Deplano, M., & Cosentino, S. (2008) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2008.49.2.119 · Cited by 28
Liu, J., Bolstad, D. B., Smith, A. E., Priestley, N. D., Wright, D. L., & Anderson, A. C. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00745.x · Cited by 26
Riddell, J., & Kauffman, C. A. (2008) · Cancer · doi:10.1002/cncr.23465 · Cited by 23
Fungal empyema thoracis in cancer patients
Nigo, M., Vial, M. R., Munita, J. M., Jiang, Y., Tarrand, J. T., Jiménez, C. A., & Kontoyiannis, D. P. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.02.014 · Cited by 28
Roles of vacuolar H+-ATPase in the oxidative stress response ofCandida glabrata
Nishikawa, H., Miyazaki, T., Nakayama, H., Minematsu, A., Yamauchi, S., Yamashita, K., Takazono, T., Shimamura, S., Nakamura, S., Izumikawa, K., et al. (2016) · FEMS Yeast Research · doi:10.1093/femsyr/fow054 · Cited by 26
Pharmacokinetic evaluation of fluconazole in critically ill patients
Sinnollareddy, M., Peake, S., Roberts, M. S., Playford, E. G., Lipman, J., & Roberts, J. A. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.615309 · Cited by 22
Groll, A. H., & Grist, L. M. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.08.014 · Cited by 25
Zaragoza, R., & Pemán, J. (2006) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(06)70014-6 · Cited by 25
Lotfi, N., Shokohi, T., Nouranibaladezaei, S., Omran, A. N., & Kondori, N. (2015) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.22929 · Cited by 22
Deorukhkar, S. C., & Saini, S. (2012) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/39 · Cited by 26
Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes
Ruan, S., Huang, Y., Chu, C.-C., Yu, C., & Hsueh, P. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.02.021 · Cited by 22
New options for treatment of candidaemia in critically ill patients
Ruhnke, M., Härtwig, K., & Kofla, G. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01981.x · Cited by 25
Lee, I., Zaoutis, T. E., Fishman, N. O., Morales, K. H., Nachamkin, I., & Lautenbach, E. (2010) · American Journal of Infection Control · doi:10.1016/j.ajic.2009.12.011 · Cited by 21
Mootsikapun, P., Hsueh, P.-R., Talwar, D., Co, V. M., Rajadhyaksha, V., & Ong, M.-L. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-219 · Cited by 20
Paulsen, J. L., Bendel, S. D., & Anderson, A. C. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01169.x · Cited by 20
Boldo‐León, X. M., Villa‐Tanaca, L., Zúñiga, G., & Hernández-Rodríguez, C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4799-4804.2003 · Cited by 23
Efficacy of caspofungin in invasive candidiasis and candidemia – de‐escalation strategy
Lichtenstern, C., Nguyen, T. H., Schemmer, P., Hoppe‐Tichy, T., & Weigand, M. A. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01527.x · Cited by 20
Hof, H. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01522.x · Cited by 22
An observational study on the epidemiological and mycological profile of Candidemia in ICU patients
Kotwal, A., Biswas, D., Sharma, J. P., Gupta, A., & Jindal, P. (2011) · Medical Science Monitor · doi:10.12659/msm.882053 · Cited by 23
Fungal Infections in Patients With Walled-off Pancreatic Necrosis
Werge, M. P., Roug, S., Novovic, S., Schmidt, P. N., Hansen, E. F., & Knudsen, J. D. (2016) · Pancreas · doi:10.1097/mpa.0000000000000675 · Cited by 19
Ramírez-Zavaleta, C. Y., Salas-Delgado, G. E., De Las Peñas, A., & Castaño, I. (2010) · Eukaryotic Cell · doi:10.1128/ec.00129-10 · Cited by 18
Auzinger, G. M., Playford, E. G., Graham, C. N., Knox, H. N., Weinstein, D. L., Kantecki, M., Schlamm, H. T., & Charbonneau, C. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1143-1 · Cited by 20
Chen, P., Lo, H., Wu, C.-J., Lee, H., Chang, C., Lee, N., Wang, A.-H., Lin, W.-L., Ko, N., Lee, C., et al. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01818.x · Cited by 22
Miyazaki, T., & Kohno, S. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1058157 · Cited by 20
Das, K. H., Mangayarkarasi, V., & Sen, M. (2019) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/1765 · Cited by 20
Rae, N., Kenny, C. C., & Muldoon, E. G. (2018) · Mycoses · doi:10.1111/myc.12874 · Cited by 19
Dignani, M. C., Solomkin, J. S., & Anaissie, E. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00008-6 · Cited by 34
Clinical consequences of resistant Candida infections in intensive care
Montravers, P., & Jabbour, K. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.11.002 · Cited by 19
Vázquez, J. A. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.6.751 · Cited by 18
Telomeric and Sub-Telomeric Structure and Implications in Fungal Opportunistic Pathogens
Diotti, R., Esposito, M. M., & Shen, C. H. (2021) · Microorganisms · doi:10.3390/microorganisms9071405 · Cited by 16
Cornely, O. A., Vázquez, J. A., Waele, J. J. D., Betts, R. F., Rotstein, C., Nucci, M., Pappas, P. G., & Ullmann, A. J. (2013) · Mycoses · doi:10.1111/myc.12104 · Cited by 22
Aikawa, N., Kusachi, S., Oda, S., Takesue, Y., & Tanaka, H. (2009) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-009-0689-5 · Cited by 18
Fidler, G., Leiter, É., Kocsubé́, S., Bíró, S., & Paholcsek, M. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3283-6 · Cited by 19
Sang-Youn, L. E. E., Lee, D.-S., Cho, S.-M., Kim, J.-C., Park, M. J., & Choi, I. (2021) · Journal of the Korean Wood Science and Technology · doi:10.5658/wood.2021.49.1.23 · Cited by 17
Malý, J., Szárszoi, O., Netuka, I., Dorazilová, Z., & Pirk, J. (2013) · Journal of Cardiac Surgery · doi:10.1111/jocs.12258 · Cited by 17
Toward a Molecular Understanding of Candida albicans Virulence
Odds, F. C., Gow, N. A. R., & Brown, A. J. P. (2014) · ASM Press eBooks · doi:10.1128/9781555815776.ch22 · Cited by 18
Effect of Branched α‐Oligomannoside Structures on Induction of Anti‐Candida Humoral Immune Response
Paulovičová, L., Paulovičová, E., Karelin, A. A., Tsvetkov, Y. E., Nifantiev, N. E., & Bystrický, S. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12044 · Cited by 17
Pfaller, M. A., Castanheira, M., Lockhart, S. R., & Jones, R. N. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0091-0 · Cited by 22
Erdem, İ., Oğuzoğlu, N., Öztürk-Engin, D., Özgültekin, A., Inan, A. S., Ceran, N., Kaya, F., Genç, İ., & Göktaş, P. (2010) · Medical Principles and Practice · doi:10.1159/000320305 · Cited by 19
Paulsen, J. L., Liu, J., Bolstad, D. B., Smith, A. E., Priestley, N. D., Wright, D. L., & Anderson, A. C. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.06.021 · Cited by 17
New Approach for Diagnosis of Candidemia Based on Detection of a 65-Kilodalton Antigen
Berzaghi, R., Colombo, A. L., Machado, A. M. D. O., & Camargo, Z. P. D. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00176-09 · Cited by 17
Antifungal Susceptibility and Risk Factors in Patients with Candidemia
Mermutluoğlu, Ç., Deveci, Ö., Hoşoğlu, S., Dayan, S., Aslan, E., Bozkurt, F., & Tekin, R. (2016) · Eurasian Journal of Medicine · doi:10.5152/eurasianmed.2016.0021 · Cited by 25
Kumar, V. G., Ragunathan, L., Vedhagiri, K., Sathiamoorthi, T., Jayarani, G., Sasikala, R., Selvin, J., & Natarajaseenivasan, K. (2008) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2008.11.002 · Cited by 31
Changing epidemiology of invasive candidiasis in intensive care units—Much ado about nothing?(*
Sobel, J. D. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318170fa45 · Cited by 17
Sidiq, F. P., Hoostal, M. J., & Rogers, S. O. (2016) · BMC Research Notes · doi:10.1186/s13104-016-2097-0 · Cited by 19
Candida kefyr, an Uncommon but Emerging Fungal Pathogen: Report of Two Cases
Corpus, K. A., Hegeman‐Dingle, R., & Bajjoka, I. E. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.11.1084.36140 · Cited by 18
Metadata
- Authors
- Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-09
- Volume
- 35
- Issue
- 5
- Pages
- 627-630
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2121025359
- Cited by
- 660
- References
- 19
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 5 · 2023: 7 · 2022: 8 · 2021: 9 · 2020: 10 · 2019: 12 · 2018: 9 · 2017: 13 · 2016: 23 · 2015: 34 · 2014: 31 · 2013: 32 · 2012: 32
- FWCI
- 22.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- Candida albicans, Candida glabrata, non-albicans Candida, bloodstream infection, intensive care unit patients, nosocomial infections, incidence trends, National Nosocomial Infections Surveillance System
- MeSH terms
- Adult, Candida, Candidiasis, Cross Infection, Female, Humans, Intensive Care Units, Male, Middle Aged, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.